1] Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, KY, USA [2] Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.
J Antibiot (Tokyo). 2014 Aug;67(8):571-5. doi: 10.1038/ja.2014.37. Epub 2014 Apr 9.
Two new cyclopeptides, mullinamides A [cyclo-(-L-Gly-L-Glu-L-Val-L-Ile-L-Pro-)] and B [cyclo-(-L-Glu-L-Met-L-Pro-)] were isolated from the crude extract of terrestrial Streptomyces sp. RM-27-46 along with the three known cyclopeptides surugamide A [cyclo-(-L-Ile-D-Ile-L-Lys-L-Ile-D-Phe-D-Leu-L-Ile-D-Ala-)], cyclo-(-L-Pro-L-Phe-) and cyclo-(-L-Pro-L-Leu-). The structures of the new compounds were elucidated by the cumulative analyses of NMR spectroscopy and HRMS. Although mullinamides A and B displayed no appreciable antimicrobial/fungal activity or cytotoxicity, this study highlights the first reported antibacterial activity of surugamide A.
两种新的环肽,mullinamides A [cyclo-(-L-Gly-L-Glu-L-Val-L-Ile-L-Pro-)]和 B [cyclo-(-L-Glu-L-Met-L-Pro-)],是从陆地链霉菌 RM-27-46 的粗提物中分离出来的,同时还分离出了三种已知的环肽 surugamide A [cyclo-(-L-Ile-D-Ile-L-Lys-L-Ile-D-Phe-D-Leu-L-Ile-D-Ala-)], cyclo-(-L-Pro-L-Phe-)和 cyclo-(-L-Pro-L-Leu-)。新化合物的结构通过 NMR 光谱和高分辨率质谱的累积分析得到阐明。尽管 mullinamides A 和 B 没有表现出明显的抗菌/抗真菌活性或细胞毒性,但这项研究突出了 surugamide A 的首次报道的抗菌活性。